Advertisement
Research Article|Articles in Press, 103700

Plasma transfusion in critically Ill patients with abnormal coagulation tests before invasive procedures: A propensity-adjusted cohort study

  • Author Footnotes
    1 Equal contributors.
    Qi Ren
    Footnotes
    1 Equal contributors.
    Affiliations
    Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China

    Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China

    Zhongshan Central Blood Station, 528405 Zhongshan, Guangdong Province, PR China
    Search for articles by this author
  • Author Footnotes
    1 Equal contributors.
    Jie Zhao
    Footnotes
    1 Equal contributors.
    Affiliations
    Sichuan Provincial People's Hospital, 610072 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Author Footnotes
    1 Equal contributors.
    Xuehua He
    Footnotes
    1 Equal contributors.
    Affiliations
    Shanxi Bethune Hospital, 030032 Taiyuan, Shanxi Province, PR China
    Search for articles by this author
  • Author Footnotes
    1 Equal contributors.
    Li Su
    Footnotes
    1 Equal contributors.
    Affiliations
    Guizhou Provincial People's Hospital, 550002 Guiyang, Guizhou Province, PR China
    Search for articles by this author
  • Author Footnotes
    1 Equal contributors.
    Juchuan Chai
    Footnotes
    1 Equal contributors.
    Affiliations
    Zibo Central Hospital, 255020 Zibo, Shandong Province, PR China
    Search for articles by this author
  • Author Footnotes
    1 Equal contributors.
    Lingling Bai
    Footnotes
    1 Equal contributors.
    Affiliations
    The Third People's Hospital of Chengdu, 610014 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Author Footnotes
    1 Equal contributors.
    Zhengcai Ao
    Footnotes
    1 Equal contributors.
    Affiliations
    Chengdu Fifth People's Hospital, Chengdu 611130, Sichuan Province, PR China
    Search for articles by this author
  • Caixia Wu
    Affiliations
    Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China

    Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Xiaoyu Guan
    Affiliations
    Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China

    Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Yudi Xie
    Affiliations
    Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China

    Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Yujie Kong
    Affiliations
    Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China

    Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Ling Li
    Correspondence
    Correspondence to: 26 Huacai Rd, Longtan Industry Zone, Chenghua District, Chengdu, Sichuan, PR China.
    Affiliations
    Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China

    Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Zhong Liu
    Correspondence
    Correspondence to: 26 Huacai Rd, Longtan Industry Zone, Chenghua District, Chengdu, Sichuan, PR China.
    Affiliations
    Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, 610052 Chengdu, Sichuan Province, PR China

    Key Laboratory of Transfusion Adverse Reactions, Chinese Academy of Medical Sciences, 610052 Chengdu, Sichuan Province, PR China
    Search for articles by this author
  • Author Footnotes
    1 Equal contributors.

      Abstract

      Objective

      To evaluate the association between plasma transfusion and bleeding complications in critically ill patients with an elevated international normalized ratios undergoing invasive procedures.

      Methods

      A retrospective study was conducted to evaluate a consecutive sample of critically ill adult patients undergoing invasive procedures (N = 487) with an international normalized ratio ≥ 1.5 between January 1, 2019 and December 31, 2019. Among the followed patients, 125 were excluded due to incomplete case records and 362 were finally included in this investigation. The exposure was whether plasma had been transfused within 24 h before the invasive procedure. The primary outcome was the occurrence of postprocedural bleeding complications. Secondary outcomes included transfusion of red blood cells within 24 h of the invasive procedure, and additional patient-important outcomes such as mortality and length of stay. Tests were performed with univariate and propensity-matched analyses.

      Results

      Of the 362 study participants, 99 (27.3 %) received a preprocedural plasma transfusion. In the propensity score-matched analysis, the rate of the occurrence of postprocedural bleeding complications between two groups was not statistically different (OR, 0.605[95 % CI, 0.341–1.071]; P = .085). The rate of postoperative red blood cell transfusion in the plasma transfusion group was higher than that in the non-plasma transfusion group (35.5 % vs 21.5 %; P < .05). No statistically significant difference in mortality was observed between the two groups (29.0 % vs 31.6 %; P = .101).

      Conclusions

      Prophylactic plasma transfusion failed to reduce postprocedural bleeding complications in ill critically patients with a coagulopathy. Meanwhile, it was associated with increased red blood cell transfusion after invasive procedures. Findings suggest that abnormal preprocedural international normalized ratios should be managed more conservatively.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Parienti J.J.
        • Mongardon N.
        • Mégarbane B.
        • et al.
        Intravascular complications of central venous catheterization by insertion site.
        N Engl J Med. 2015; 373: 1220-1229
        • McGee D.C.
        • Gould M.K.
        Preventing complications of central venous catheterization.
        N Engl J Med. 2003; 348: 1123-1133
        • Brass P.
        • Hellmich M.
        • Kolodziej L.
        • et al.
        Ultrasound guidance versus anatomical landmarks for subclavian or femoral vein catheterization.
        Cochrane Database Syst Rev. 2015; 1: CD011447
        • Müller M.C.
        • Straat M.
        • Meijers J.C.
        • et al.
        Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy.
        J Thromb Haemost. 2015; 13: 989-997
        • Chowdary P.
        • Saayman A.G.
        • Paulus U.
        • et al.
        Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.
        Br J Haematol. 2004; 125: 69-73
        • O'Shaughnessy D.F.
        • Atterbury C.
        • Bolton Maggs P.
        • et al.
        Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.
        Br J Haematol. 2004; 126: 11-28
        • Gulati G.
        • Hevelow M.
        • George M.
        • et al.
        International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy.
        Arch Pathol Lab Med. 2011; 135: 490-494
        • Walsh T.S.
        • Stanworth S.J.
        • Prescott R.J.
        • et al.
        Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units.
        Crit Care Med. 2010; 38: 1939-1946
        • Stanworth S.J.
        • Walsh T.S.
        • Prescott R.J.
        • et al.
        A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.
        Crit Care. 2011; 15: R108
        • Toy P.
        • Gajic O.
        • Bacchetti P.
        • et al.
        Transfusion-related acute lung injury:incidence and risk factors.
        Blood. 2012; 119: 1757-1767
        • von Elm E.
        • Altman D.G.
        • Egger M.
        • et al.
        TROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.
        J Clin Epidemiol. 2007; 370: 1453-1457
        • Arnold D.M.
        • Donahoe L.
        • Clarke F.J.
        • et al.
        Bleeding during critical illness: a prospective cohort study using a new measurement tool.
        Clin Invest Med. 2007; 30: E93-E102
        • Dzik W.
        • Rao A.
        Why do physicians request fresh frozen plasma?.
        Transfusion. 2004; 44: 1393-1394
        • Cheves J.W.
        • DeMarinis S.
        • Sorin C.
        • et al.
        Causes of an elevated international normalized ratio in the intensive care unit and the implications for plasma transfusion.
        Transfusion. 2021; 61: 2862-2868
        • Desborough M.
        • Stanworth S.
        Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.
        Transfusion. 2012; 52: 20S-29SS
        • Abdel-Wahab O.I.
        • Healy B.
        • Dzik W.H.
        Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
        Transfusion. 2006; 46: 1279-1285
        • Ng K.F.
        • Lai K.W.
        • Tsang S.F.
        Value of preprocedural coagulation tests: reappraisal of major noncardiac surgery.
        World J Surg. 2002; 26: 515-520
        • Segal J.B.
        • Dzik W.H.
        Transfusion Medicine/Hemostasis Clinical Trials Network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review.
        Transfusion. 2005; 45: 1413-1425
        • Warner M.A.
        • Frank R.D.
        • Weister T.J.
        • et al.
        Higher intraoperative plasma transfusion volumes are associated with inferior perioperative outcomes.
        Transfusion. 2019; 59: 112-124
        • Shannon E.
        • Arthur W.B.
        • Andrew E.H.
        Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists.
        JAMA. 1994; 271: 777-781
        • Stanworth S.J.
        • Brunskill S.J.
        • Hyde C.J.
        • et al.
        Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials.
        Br J Haematol. 2004; 126: 139-152
        • Doerfler M.E.
        • Kaufman B.
        • Goldenberg A.S.
        Central venous catheter placement in patients with disorders of hemostasis.
        Chest. 1996; 110: 185-188
        • Malloy P.C.
        • Grassi C.J.
        • Kundu S.
        • et al.
        Standards of Practice Committee with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.
        J Vasc Inter Radiol. 2009; 20: S240-S249
        • de Bruin S.
        • Scheeren T.W.L.
        • Bakker J.
        • et al.
        Cardiovascular Dynamics Section and Transfusion Guideline Task Force of the ESICM. Transfusion practice in the non-bleeding critically ill: an international online survey-the TRACE survey.
        Crit Care. 2019; 23: 309
        • Sarani B.
        • Dunkman W.J.
        • Dean L.
        • et al.
        Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection.
        Crit Care Med. 2008; 36: 1114-1118
        • Eder A.F.
        • Herron Jr, R.M.
        • Strupp A.
        • et al.
        Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008).
        Transfusion. 2010; 50: 1732-1742